BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27631845)

  • 1. VISUAL VIGNETTE.
    Narwani V; Kempf J; Lubitz S
    Endocr Pract; 2017 May; 23(5):633. PubMed ID: 27631845
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual vignette.
    Saberi S; Esfandiari NH
    Endocr Pract; 2015 May; 21(5):558. PubMed ID: 25297672
    [No Abstract]   [Full Text] [Related]  

  • 3. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
    Rosario PW
    Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
    [No Abstract]   [Full Text] [Related]  

  • 4. [Axillary metastasis of papillary thyroid carcinoma: report of a case].
    El Khiati R; Ouaissi L; Rouadi S; Abada R; Mahtar M; Roubal M; Janah A; Essaadi M; Kadiri F
    Pan Afr Med J; 2013; 16():12. PubMed ID: 24498461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.
    Rosario PW; Mourão GF; Siman TL; Calsolari MR
    Endocrine; 2015 May; 49(1):279-82. PubMed ID: 25205448
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioiodine therapy for thyroid cancer depicted uterine leiomyoma.
    Hirata K; Shiga T; Kubota KC; Okamoto S; Kamibayashi T; Tamaki N
    Clin Nucl Med; 2009 Mar; 34(3):180-1. PubMed ID: 19352287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
    Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
    Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
    [No Abstract]   [Full Text] [Related]  

  • 8. Metachronous solitary metastasis of papillary thyroid cancer in the cavernous sinus: case report and review of literature.
    Chandarana MN; Epari S; Chaukar D; Moiyadi AV
    J Cancer Res Ther; 2012; 8(3):436-8. PubMed ID: 23174730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
    Marti JL; Davies L; Haymart MR; Roman BR; Tuttle RM; Morris LG
    Thyroid; 2015 Jul; 25(7):865-6. PubMed ID: 25963001
    [No Abstract]   [Full Text] [Related]  

  • 11. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer.
    Nixon IJ; Ganly I
    Future Oncol; 2013 Jul; 9(7):921-3. PubMed ID: 23837752
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastases in the sphenoidal sinus in a patient with papillary thyroid cancer.
    Argibay Vázquez S; Lancha Hernández C; Martínez Muñiz A
    Clin Transl Oncol; 2005 Aug; 7(7):324-7. PubMed ID: 16185596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid Carcinoma.
    Suman P; Wang CH; Moo-Young TA; Prinz RA; Winchester DJ
    Am Surg; 2016 Sep; 82(9):807-14. PubMed ID: 27670568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarkable response to radioiodine therapy in a case of metastatic macrofollicular variant of papillary thyroid carcinoma.
    Marques P; Leite V; Bugalho MJ
    Clin Nucl Med; 2014 Feb; 39(2):219-21. PubMed ID: 24368535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 19. Discussion.
    J Am Coll Surg; 2015 Apr; 220(4):625-7. PubMed ID: 25797748
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid carcinoma.
    Bell RM
    Surg Clin North Am; 1986 Feb; 66(1):13-30. PubMed ID: 3511551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.